A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma

Ophthalmology. 1998 Nov;105(11):2035-45. doi: 10.1016/S0161-6420(98)91121-6.

Abstract

Objective: To determine the causes and patterns of mortality after uveal melanoma radiation.

Design: A cohort study from a single institution was performed. Mortality was modeled using semiparametric survival techniques. All cause and cause-specific mortality analyses were performed. Mortality was compared with expected mortality from the U.S. census data.

Participants: A total of 731 patients were studied, and 710 (97%) of these had medium or large melanomas. The mean tumor diameter was 11.3 mm, and the mean tumor thickness was 5.8 mm. Ciliary body was involved in 122 (17%) of patients. Complete follow-up was available on 99.6% (728 of 731) of patients.

Main outcome measures: The authors analyzed the distribution and causes of post-treatment mortality.

Results: The 5- and 10-year all-cause Kaplan-Meier survival rates were 75.6% and 62.3%, respectively. Both melanoma risk factors (older age, ciliary body involvement, and larger tumor diameter) and nonmelanoma risk factors (older age and medical condition) were significant prognostic factors of all-cause mortality. Deaths from nonmelanoma causes accounted for 91 (42.3%) of 215 deaths. The 5-year and 10-year estimates of nonmelanoma deaths were 8.3% and 15.9%, respectively. Nonmelanoma mortality was similar to that observed in the general U.S. population (91 observed, 98.1 expected). Melanoma metastases accounted for 124 (57.7%) of 215 deaths. The 5- and 10-year estimates for probability of metastatic death were 16.1% and 21.8%, respectively. The largest tumor diameter was the best predictor for melanoma mortality; ciliary body involvement, older age, and distance from the fovea also were significant in multivariate analyses.

Conclusion: A significant proportion of patients with uveal melanoma die of nonmelanoma causes after radiation. In analyzing prognostic factors, considerable information may be lost if analyses are based on all-cause mortality rather than cause-specific mortality.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Brachytherapy*
  • Causality
  • Cause of Death
  • Cohort Studies
  • Female
  • Humans
  • Male
  • Melanoma / mortality*
  • Melanoma / pathology
  • Melanoma / radiotherapy
  • Middle Aged
  • Neoplasm Metastasis
  • Radiotherapy, High-Energy*
  • San Francisco / epidemiology
  • Survival Rate
  • Uveal Neoplasms / mortality*
  • Uveal Neoplasms / pathology
  • Uveal Neoplasms / radiotherapy